Mark For: EMLIRU™ trademark registration is intended to cover the categories of pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain.
Status
2021-07-25 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.
(Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use
No
Current Use
No
Intent To Use
Yes
Filed ITU
Yes
44D Filed
No
44E Current
No
66A Current
No
Current Basis
No
No Basis
No
Attorney Name
Bruce W. Longbottom
Law Office Assigned
L70
Employee Name
DINALLO, KEVIN M
Timeline
2018-04-09
Application Filed
2018-09-04
Published
2018-09-04
Published for Opposition
2019-03-07
Location: INTENT TO USE SECTION
2019-09-25
Status: Live/Pending
2019-09-27
Transaction Date
2021-04-06
Status: A fifth request for extension of time to file a Statement of Use has been granted.
BRUCE W. LONGBOTTOM ELI LILLY AND COMPANY LILLY CORPORATE CENTER INDIANAPOLIS IN 46285
Good, Services, and Codes
International Codes:
5
U.S. Codes:
006,018,044,046,051,052
Type Code
Type
GS0051
Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic agents and substances for medical purposes; Radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases
Trademark Filing History
Description
Date
Proceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-04-07
EXTENSION 5 GRANTED
2021-04-06
66530
TEAS EXTENSION RECEIVED
2021-03-31
EXTENSION 5 FILED
2021-03-31
66530
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-09-22
EXTENSION 4 GRANTED
2020-09-21
66530
TEAS EXTENSION RECEIVED
2020-09-16
EXTENSION 4 FILED
2020-09-16
66530
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2020-03-21
TEAS EXTENSION RECEIVED
2020-03-19
EXTENSION 3 GRANTED
2020-03-19
98765
EXTENSION 3 FILED
2020-03-19
98765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-09-27
TEAS EXTENSION RECEIVED
2019-09-25
EXTENSION 2 GRANTED
2019-09-25
98765
EXTENSION 2 FILED
2019-09-25
98765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2019-03-08
EXTENSION 1 GRANTED
2019-03-07
66530
CASE ASSIGNED TO INTENT TO USE PARALEGAL
2019-03-07
66530
TEAS EXTENSION RECEIVED
2019-02-28
EXTENSION 1 FILED
2019-02-28
66530
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2018-10-30
PUBLISHED FOR OPPOSITION
2018-09-04
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2018-09-04
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2018-08-15
ASSIGNED TO EXAMINER
2018-07-26
78179
APPROVED FOR PUB - PRINCIPAL REGISTER
2018-07-26
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.